2019 Q4 Form 10-Q Financial Statement

#000120179219000013 Filed on November 12, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q3
Revenue $74.38M $67.89M $72.99M
YoY Change -3.31% -6.99% -0.39%
Cost Of Revenue $28.01M $27.27M $28.19M
YoY Change -1.51% -3.26% -1.86%
Gross Profit $46.37M $40.62M $44.81M
YoY Change -4.37% -9.34% 0.55%
Gross Profit Margin 62.34% 59.83% 61.38%
Selling, General & Admin $33.89M $37.89M $33.44M
YoY Change 3.61% 13.33% 4.89%
% of Gross Profit 73.09% 93.29% 74.63%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.840M $3.770M $4.290M
YoY Change -11.52% -12.12% -8.53%
% of Gross Profit 8.28% 9.28% 9.57%
Operating Expenses $37.73M $37.89M $33.44M
YoY Change 1.81% 13.33% 4.89%
Operating Profit $8.640M -$2.913M $6.884M
YoY Change -24.41% -142.32% -9.41%
Interest Expense $700.0K $1.019M $774.0K
YoY Change -29.29% 31.65% 4452.94%
% of Operating Profit 8.1% 11.24%
Other Income/Expense, Net
YoY Change
Pretax Income $9.310M -$1.894M $7.658M
YoY Change -25.03% -124.73% 0.55%
Income Tax $3.590M -$239.0K $1.848M
% Of Pretax Income 38.56% 24.13%
Net Earnings $5.719M -$1.638M $5.499M
YoY Change -37.11% -129.79% 25.95%
Net Earnings / Revenue 7.69% -2.41% 7.53%
Basic Earnings Per Share $0.37 -$0.10 $0.33
Diluted Earnings Per Share $0.37 -$0.10 $0.33
COMMON SHARES
Basic Shares Outstanding 15.40M shares 15.97M shares 16.42M shares
Diluted Shares Outstanding 16.12M shares 16.66M shares

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $202.7M $210.1M $197.6M
YoY Change -4.43% 6.33% 18.82%
Cash & Equivalents $202.7M $210.1M $197.6M
Short-Term Investments
Other Short-Term Assets $7.100M $6.300M $5.700M
YoY Change 29.09% 10.53% -14.93%
Inventory
Prepaid Expenses $7.087M $6.316M $5.664M
Receivables $11.33M $7.942M $13.27M
Other Receivables $1.800M $5.700M $3.200M
Total Short-Term Assets $222.9M $230.0M $219.7M
YoY Change -4.15% 4.68% 22.03%
LONG-TERM ASSETS
Property, Plant & Equipment $78.50M $78.67M $84.85M
YoY Change -9.65% -7.28% -7.94%
Goodwill $26.56M $26.56M $33.90M
YoY Change -21.64% -21.64% 0.0%
Intangibles $3.721M
YoY Change -7.96%
Long-Term Investments $10.50M $10.50M $12.00M
YoY Change 56.72% -12.5% -18.46%
Other Assets $4.770M $5.049M $7.548M
YoY Change -15.46% -33.11% -16.7%
Total Long-Term Assets $132.0M $131.1M $138.3M
YoY Change -4.62% -5.2% -7.71%
TOTAL ASSETS
Total Short-Term Assets $222.9M $230.0M $219.7M
Total Long-Term Assets $132.0M $131.1M $138.3M
Total Assets $354.9M $361.1M $358.0M
YoY Change -4.33% 0.86% 8.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.546M $3.965M $4.303M
YoY Change -61.08% -7.85% -14.64%
Accrued Expenses $8.270M $7.932M $14.47M
YoY Change 117.17% -45.17% 6.27%
Deferred Revenue $17.40M $20.61M $22.19M
YoY Change -4.92% -7.13%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $45.28M $45.70M $40.96M
YoY Change 2.14% 11.56% 0.77%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $9.500M $8.700M
YoY Change
Total Long-Term Liabilities $9.500M $8.700M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $45.28M $45.70M $40.96M
Total Long-Term Liabilities $9.500M $8.700M $0.00
Total Liabilities $58.16M $60.33M $47.97M
YoY Change 17.05% 25.75% -3.82%
SHAREHOLDERS EQUITY
Retained Earnings $106.0M $110.9M $124.8M
YoY Change -20.88% -11.14% 24.65%
Common Stock $190.8M $189.8M $185.2M
YoY Change 1.83% 2.5% 2.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $296.7M $300.8M $310.1M
YoY Change
Total Liabilities & Shareholders Equity $354.9M $361.1M $358.0M
YoY Change -4.33% 0.86% 8.52%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q3
OPERATING ACTIVITIES
Net Income $5.719M -$1.638M $5.499M
YoY Change -37.11% -129.79% 25.95%
Depreciation, Depletion And Amortization $3.840M $3.770M $4.290M
YoY Change -11.52% -12.12% -8.53%
Cash From Operating Activities $6.430M $8.220M $5.990M
YoY Change -65.47% 37.23% -53.89%
INVESTING ACTIVITIES
Capital Expenditures -$3.110M $1.194M $1.549M
YoY Change -23.77% -22.92% -43.75%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$3.110M -$1.190M -$1.790M
YoY Change -23.77% -33.52% -53.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.70M -17.75M -200.0K
YoY Change 8775.0%
NET CHANGE
Cash From Operating Activities 6.430M 8.220M 5.990M
Cash From Investing Activities -3.110M -1.190M -1.790M
Cash From Financing Activities -10.70M -17.75M -200.0K
Net Change In Cash -7.380M -10.72M 4.000M
YoY Change -150.76% -368.0% -56.19%
FREE CASH FLOW
Cash From Operating Activities $6.430M $8.220M $5.990M
Capital Expenditures -$3.110M $1.194M $1.549M
Free Cash Flow $9.540M $7.026M $4.441M
YoY Change -57.97% 58.21% -56.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6192000 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14059000 USD
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7942000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3808000 USD
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7932000 USD
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
187172000 USD
CY2019Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
189691000 USD
apei Equity Investment Income Loss After Tax
EquityInvestmentIncomeLossAfterTax
-483000 USD
apei Equity Investment Income Loss After Tax
EquityInvestmentIncomeLossAfterTax
-1464000 USD
apei Increase Decrease In Operating Leases Net
IncreaseDecreaseInOperatingLeasesNet
0 USD
apei Increase Decrease In Operating Leases Net
IncreaseDecreaseInOperatingLeasesNet
-361000 USD
CY2019Q3 apei Lessee Operating Lease Liability Payments Due After Year Six
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix
2239000 USD
CY2019Q3 apei Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
566000 USD
apei Number Of Students
NumberOfStudents
82100 student
apei Number Of Subsidiaries
NumberOfSubsidiaries
2 subsidiary
CY2019Q3 apei Operating Lease Additional Right Of Use Asset
OperatingLeaseAdditionalRightOfUseAsset
0 USD
apei Operating Lease Additional Right Of Use Asset
OperatingLeaseAdditionalRightOfUseAsset
0 USD
CY2018Q4 apei Students Deposits
StudentsDeposits
8400000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001201792
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15398238 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
AMERICAN PUBLIC EDUCATION INC
dei Entity Shell Company
EntityShellCompany
false
dei Entity Small Business
EntitySmallBusiness
false
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9110000 USD
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3965000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5031000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-524000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-315000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-303000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
872000 USD
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2084000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5524000 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1712000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5031000 USD
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6648000 USD
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6403000 USD
CY2018Q4 us-gaap Assets
Assets
370958000 USD
CY2019Q3 us-gaap Assets
Assets
361106000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
232570000 USD
CY2019Q3 us-gaap Assets Current
AssetsCurrent
230010000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
179205000 USD
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
197596000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
212131000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
210103000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
18391000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2028000 USD
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16425000 shares
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15627000 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16425000 shares
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15627000 shares
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
164000 USD
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
156000 USD
CY2018Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
CY2019Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18310000 USD
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
20608000 USD
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28186000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
86839000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
27268000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
83908000 USD
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
66108000 USD
us-gaap Costs And Expenses
CostsAndExpenses
199663000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
70801000 USD
us-gaap Costs And Expenses
CostsAndExpenses
207742000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
732000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
599000 USD
CY2018Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
5364000 USD
CY2019Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
5963000 USD
CY2018Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4289000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
832000 USD
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
231000 shares
us-gaap Depreciation And Amortization
DepreciationAndAmortization
11758000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
13158000 USD
CY2019Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3764000 USD
CY2018Q3 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-196000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-882000 USD
CY2019Q3 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-394000 USD
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
152000 shares
CY2019Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11191000 USD
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.01
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.00
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
13100000 USD
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19298000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
55780000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22021000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
59209000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
33899000 USD
CY2019Q3 us-gaap Goodwill
Goodwill
26563000 USD
CY2018Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2019Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1481000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
7336000 USD
CY2019Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 USD
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
7658000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
23022000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1894000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
7354000 USD
CY2018Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-311000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-483000 USD
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
17000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1464000 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1848000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5993000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-239000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1596000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
10041000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
5749000 USD
CY2018Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
898000 USD
CY2019Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
5649000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4541000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5145000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6138000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6117000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1522000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4405000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1909000 USD
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-4907000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2539000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2298000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
32000 USD
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-4751000 USD
CY2018Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
234000 shares
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
154000 shares
CY2018Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
774000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1928000 USD
CY2019Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1019000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3207000 USD
CY2018Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
11966000 USD
CY2019Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
10502000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
12479000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1800000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1523000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2481000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2537000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2517000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
616000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1810000 USD
CY2019Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2019Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P62M
CY2018Q4 us-gaap Liabilities
Liabilities
49692000 USD
CY2019Q3 us-gaap Liabilities
Liabilities
60328000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
370958000 USD
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
361106000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
44328000 USD
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
45697000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1815000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-29813000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5349000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4151000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25555000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
31936000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
5499000 USD
us-gaap Net Income Loss
NetIncomeLoss
16546000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-1638000 USD
us-gaap Net Income Loss
NetIncomeLoss
4294000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
6884000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
21094000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2913000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
4147000 USD
CY2019Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
600000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
1900000 USD
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
10669000 USD
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2001000 USD
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8668000 USD
CY2019Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
600000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1800000 USD
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y10M0D
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.051
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10308000 USD
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11800000 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5642000 USD
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5049000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-280000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-83000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1815000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
29813000 USD
CY2018Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1549000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5349000 USD
CY2019Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1194000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4151000 USD
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5482000 USD
CY2019Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6316000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
86881000 USD
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78674000 USD
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1700000 USD
CY2019Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1300000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
133930000 USD
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
110931000 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
72992000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
220757000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
67888000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
211889000 USD
CY2018Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14139000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
43004000 USD
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15873000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
45007000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
5524000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
5031000 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
0 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
0 USD
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
27303000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1815000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2510000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
289406000 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
310051000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
321266000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
300778000 USD
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16658159 shares
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16658000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16627532 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16628000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16120779 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16335000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16121000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16486837 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16487000 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16424000 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16423548 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16397483 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16397000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15966789 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15967000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16335097 shares
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nature of the Business</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">American Public Education, Inc., or APEI, which together with its subsidiaries is referred to as the &#8220;Company,&#8221; is a provider of online and campus-based postsecondary education to approximately </font><font style="font-family:inherit;font-size:10pt;">82,100</font><font style="font-family:inherit;font-size:10pt;"> students through </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> subsidiary institutions:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">American Public University System, Inc., or APUS, provides online postsecondary education directed primarily at the needs of the military, military-affiliated, and public service communities through American Military University, or AMU, and American Public University, or APU.&#160;APUS is regionally accredited by the Higher Learning Commission and several of its academic programs have specialized accreditation granted by industry-governing organizations.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">National Education Seminars, Inc., which is referred to herein as Hondros College of Nursing, or HCN,&#160;provides nursing education to students at </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> campuses in Ohio to serve the needs of the nursing and healthcare communities. HCN is nationally accredited by the Accrediting Bureau for Health Education Schools, or ABHES.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s institutions are licensed or otherwise authorized, or are in the process of obtaining such licenses or authorizations, to offer postsecondary education programs by state authorities to the extent the institutions believe such licenses or authorizations are required, and are certified by the United States Department of Education, or ED, to participate in student financial aid programs authorized under Title IV of the Higher Education Act of 1965, as amended, or Title IV programs.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s operations are organized into </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> reportable segments:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">American Public Education Segment, </font><font style="font-family:inherit;font-size:10pt;">or</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> APEI Segment.</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">This segment reflects the operational activities at APUS, other corporate activities, and minority investments.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Hondros College of Nursing Segment, </font><font style="font-family:inherit;font-size:10pt;">or</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> HCN Segment.</font><font style="font-family:inherit;font-size:10pt;">&#160;This segment reflects the operational activities of HCN.</font></div></td></tr></table></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In preparing financial statements in conformity with GAAP, the Company is required to make estimates and judgments that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. The Company evaluates these estimates and judgments on an ongoing basis and bases its estimates on experience, current and expected future conditions, and various other assumptions that the Company believes are reasonable under the circumstances. Actual results may differ from these estimates.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

Files In Submission

Name View Source Status
0001201792-19-000013-index-headers.html Edgar Link pending
0001201792-19-000013-index.html Edgar Link pending
0001201792-19-000013.txt Edgar Link pending
0001201792-19-000013-xbrl.zip Edgar Link pending
apei-20190930.xml Edgar Link completed
apei-20190930.xsd Edgar Link pending
apei-20190930_cal.xml Edgar Link unprocessable
apei-20190930_def.xml Edgar Link unprocessable
apei-20190930_lab.xml Edgar Link unprocessable
apei-20190930_pre.xml Edgar Link unprocessable
apeiq30930201910q.htm Edgar Link pending
exhibit101_q319.htm Edgar Link pending
exhibit102_q319.htm Edgar Link pending
exhibit311_q319.htm Edgar Link pending
exhibit312_q319.htm Edgar Link pending
exhibit321_q319.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image0a17.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending